Stock listing
TWSE:4737 Bionime Corporation (華廣) 股價
Follow Bionime Corporation into a list and get an email when it puts out news.
Share price · TWSE:4737
$58.00 TWD -1.40 (-2.4%)
Close on Nov 20, 2026
- Day range
- $57.10 – $58.90 TWDNov 20, 2026
- Volume
- 134,698 sharesNov 20, 2026
- Market cap
- $4.48B TWDAt the close on Nov 20, 2026 · price × 77.29M shares outstanding
- 52-week range
- $49.75 – $72.90 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $4.90M TWDMedian day 54,564 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:4737 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $58.00 | -1.40 | -2.4% | $57.60 | $58.90 | $57.10 | 134,698 | |
| $59.40 | -0.20 | -0.3% | $59.60 | $62.00 | $59.20 | 164,017 | |
| $59.60 | +2.90 | +5.1% | $56.60 | $61.50 | $56.40 | 336,512 | |
| $56.70 | +0.60 | +1.1% | $55.50 | $56.90 | $55.20 | 32,004 | |
| $56.10 | +0.80 | +1.4% | $55.90 | $56.80 | $55.90 | 25,010 | |
| $55.30 | -0.40 | -0.7% | $57.10 | $57.70 | $55.30 | 53,033 | |
| $55.70 | +0.20 | +0.4% | $55.10 | $55.70 | $55.10 | 11,037 | |
| $55.50 | -1.80 | -3.1% | $55.50 | $56.70 | $55.40 | 52,118 | |
| $57.30 | +1.50 | +2.7% | $56.60 | $58.00 | $56.00 | 62,641 | |
| $55.80 | -0.20 | -0.4% | $50.60 | $55.80 | $50.60 | 89,321 | |
| $56.00 | -0.90 | -1.6% | $56.90 | $57.00 | $55.30 | 45,331 | |
| $56.90 | -1.50 | -2.6% | $57.70 | $57.70 | $55.00 | 98,249 | |
| $58.40 | -0.70 | -1.2% | $58.70 | $59.40 | $57.30 | 93,288 | |
| $59.10 | -6.50 | -9.9% | $64.80 | $64.80 | $59.10 | 256,986 | |
| $65.60 | +5.30 | +8.8% | $60.60 | $65.60 | $59.70 | 453,668 | |
| $60.30 | +0.30 | +0.5% | $60.00 | $60.50 | $59.20 | 70,225 | |
| $60.00 | -0.50 | -0.8% | $60.60 | $60.80 | $59.50 | 83,517 | |
| $60.50 | +0.60 | +1.0% | $58.10 | $60.50 | $57.80 | 103,763 | |
| $59.90 | 0.00 | 0.0% | $59.90 | $59.90 | $59.90 | 0 | |
| $59.90 | +2.90 | +5.1% | $57.20 | $59.90 | $56.60 | 64,203 | |
| $57.00 | +1.00 | +1.8% | $56.10 | $57.00 | $56.00 | 49,277 | |
| $56.00 | -0.50 | -0.9% | $55.10 | $56.50 | $55.10 | 51,004 | |
| $56.50 | 0.00 | 0.0% | $57.00 | $57.00 | $55.90 | 70,010 | |
| $56.50 | +1.10 | +2.0% | $55.50 | $56.80 | $55.50 | 84,107 | |
| $55.40 | +0.10 | +0.2% | $55.30 | $55.60 | $54.40 | 55,127 | |
| $55.30 | -0.70 | -1.3% | $56.00 | $56.00 | $54.40 | 44,050 | |
| $56.00 | -0.20 | -0.4% | $56.20 | $56.20 | $54.90 | 41,100 | |
| $56.20 | +1.20 | +2.2% | $56.10 | $56.50 | $55.80 | 13,000 | |
| $55.00 | 0.00 | 0.0% | $55.50 | $55.60 | $54.80 | 18,000 | |
| $55.00 | -0.30 | -0.5% | $55.40 | $55.70 | $55.00 | 45,000 | |
| $55.30 | 0.00 | 0.0% | $56.70 | $56.70 | $55.20 | 24,000 | |
| $55.30 | -1.00 | -1.8% | $56.80 | $56.80 | $55.20 | 44,000 | |
| $56.30 | +0.90 | +1.6% | $56.30 | $56.30 | $55.00 | 50,000 | |
| $55.40 | 0.00 | 0.0% | $55.30 | $56.10 | $55.00 | 38,000 | |
| $55.40 | -0.20 | -0.4% | $56.40 | $56.70 | $55.40 | 45,691 | |
| $55.60 | -0.70 | -1.2% | $56.80 | $56.80 | $55.50 | 21,000 | |
| $56.30 | -1.60 | -2.8% | $57.10 | $57.10 | $55.80 | 70,001 | |
| $57.90 | -1.70 | -2.9% | $59.60 | $59.80 | $57.90 | 43,000 | |
| $59.60 | -0.90 | -1.5% | $60.40 | $60.40 | $59.60 | 23,000 | |
| $60.50 | +0.20 | +0.3% | $60.20 | $60.50 | $59.90 | 51,815 | |
| $60.30 | 0.00 | 0.0% | $60.70 | $60.80 | $59.30 | 61,000 | |
| $60.30 | +0.60 | +1.0% | $59.60 | $60.50 | $58.20 | 154,000 | |
| $59.70 | +3.20 | +5.7% | $56.40 | $59.80 | $55.80 | 344,005 | |
| $56.50 | +2.50 | +4.6% | $54.00 | $56.50 | $53.30 | 61,687 | |
| $54.00 | -4.40 | -7.5% | $57.50 | $58.40 | $53.20 | 210,001 | |
| $58.40 | +0.10 | +0.2% | $58.20 | $58.40 | $56.90 | 78,000 | |
| $58.30 | +0.10 | +0.2% | $58.20 | $58.40 | $57.60 | 81,000 | |
| $58.20 | -0.60 | -1.0% | $58.80 | $58.80 | $57.70 | 98,270 | |
| $58.80 | -0.20 | -0.3% | $58.70 | $58.80 | $57.20 | 82,000 | |
| $59.00 | +0.40 | +0.7% | $58.60 | $59.10 | $58.30 | 157,001 | |
| $58.60 | +0.90 | +1.6% | $57.80 | $58.80 | $57.30 | 208,000 | |
| $57.70 | +0.30 | +0.5% | $57.40 | $57.70 | $56.80 | 62,001 | |
| $57.40 | -0.10 | -0.2% | $57.00 | $57.80 | $56.50 | 53,000 | |
| $57.50 | -0.10 | -0.2% | $57.00 | $57.60 | $56.70 | 67,000 | |
| $57.60 | -0.20 | -0.3% | $57.80 | $58.40 | $56.80 | 54,000 | |
| $57.80 | +0.20 | +0.3% | $57.70 | $58.30 | $57.00 | 120,000 | |
| $57.60 | 0.00 | 0.0% | $57.80 | $57.90 | $57.00 | 29,300 | |
| $57.60 | +0.70 | +1.2% | $56.90 | $57.70 | $56.90 | 43,000 | |
| $56.90 | +0.40 | +0.7% | $56.90 | $56.90 | $56.50 | 24,000 | |
| $56.50 | -0.50 | -0.9% | $57.20 | $57.30 | $56.50 | 20,000 | |
| $57.00 | -0.30 | -0.5% | $57.50 | $57.60 | $56.10 | 41,000 | |
| $57.30 | +0.30 | +0.5% | $57.40 | $57.60 | $57.00 | 24,000 |
Splits
1 split · TWSE:4737 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 11-for-10 | Split |
- Ticker
- TWSE:4737
- Asset type
- Stock
- Exchange
- TWSE
- Currency
- TWD
Latest news
Bionime Corporation on 6ix
- News releases
- 10 in all · newest Aug 4, 2022 · oldest 2022
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $6.69B TWD
- P/E
- Loss
- EV/sales
- 3.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.1×
- Gross margin
- 32.7%
- Operating margin
- −18.0%
- Net margin
- −16.6%
- Debt to equity
- 1.3×
- Beta
- No index for this market yet
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | Aug 14, 2024 · Before open | +1.4% |
| Q1 2024 | May 10, 2024 · Before open | −1.1% |
| Q1 2023 | May 10, 2023 · Before open | +0.5% |
| Q4 2022 | Mar 15, 2023 · Before open | −0.1% |
| Q3 2022 | Nov 10, 2022 · Before open | +0.9% |
| Q2 2022 | Aug 31, 2022 | −3.8% |
| Q1 2022 | Jun 1, 2022 | +2.3% |
| Q4 2021 | Mar 2, 2022 | −0.6% |
| Q3 2021 | Dec 1, 2021 | +1.0% |
| Quarter to Jun 30, 2021 | Aug 11, 2021 · After close | +0.7% |
All 12 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2021 | May 12, 2021 · Before open | −6.9% |
| Quarter to Dec 31, 2020 | Mar 3, 2021 | +0.1% |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.84B | 1.93B | 1.76B | 2.21B | 1.85B | 1.67B | 2.17B | 2.01B | 1.82B | 1.74B |
| Cost of revenue | 1.21B | 1.17B | 1.04B | 1.21B | 1.07B | 919.5M | 1.22B | 1.09B | 1.02B | 969.8M |
| Gross profit | 627.8M | 768.4M | 715.6M | 1.00B | 783.1M | 749.1M | 948.4M | 917.0M | 795.8M | 770.5M |
| Research and development | 354.8M | 322.3M | 242.3M | 202.0M | 187.9M | 247.9M | 255.1M | 201.2M | 160.0M | 140.4M |
| Selling, general and administrative | 476.3M | 247.5M | 243.8M | 241.6M | 237.8M | 221.0M | 250.3M | 227.1M | 215.3M | 221.9M |
| Operating income | -197.4M | -129.1M | -13.3M | 146.7M | 73.1M | 75.9M | 176.5M | 239.3M | 248.4M | 258.4M |
| Depreciation and amortization | 182.3M | 182.8M | 163.4M | 153.2M | 154.7M | 163.5M | 164.5M | 151.3M | 145.8M | 158.0M |
| EBITDA | -15.1M | 53.8M | 150.1M | 299.9M | 227.7M | 239.4M | 341.0M | 390.6M | 394.2M | 416.4M |
| Interest expense | 64.9M | 62.2M | 48.2M | 30.6M | 19.1M | 21.6M | 31.8M | 29.0M | 22.5M | 22.4M |
| Income before tax | -249.4M | -185.7M | -31.9M | 86.5M | 74.6M | 31.1M | 134.6M | 162.0M | 188.8M | 213.9M |
| Income tax | -70.1M | -59.7M | -38.4M | -5.34M | -14.7M | -32.4M | 27.9M | 34.1M | 39.2M | 35.1M |
| Net income | -180.3M | -127.2M | 6.21M | 91.0M | 87.4M | 62.4M | 106.3M | 128.0M | 149.6M | 178.8M |
| Earnings per share, basic | -2.65 | -1.90 | 0.09 | 1.35 | 1.31 | 0.94 | 1.64 | 2.00 | 2.27 | 2.55 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 423.1M | 321.2M | 391.8M | 214.5M | 253.1M | 343.2M | 359.6M | 433.6M | 174.3M | 588.9M |
| Short-term investments | 61.9M | 61.4M | 57.4M | 63.4M | 59.8M | 56.0M | 22.4M | 38.6M | 312.3M | 400.0M |
| Receivables | 540.5M | 722.8M | 520.4M | 707.2M | 387.1M | 477.7M | 752.1M | 838.6M | 625.8M | 419.3M |
| Inventory | 456.4M | 571.1M | 491.3M | 538.4M | 590.2M | 520.1M | 395.4M | 412.4M | 364.4M | 310.9M |
| Current assets | 1.56B | 1.77B | 1.62B | 1.64B | 1.39B | 1.46B | 1.60B | 1.77B | 1.49B | 1.75B |
| Property, plant and equipment | 2.48B | 2.54B | 2.63B | 2.68B | 2.69B | 2.71B | 2.73B | |||
| Goodwill | 493.0M | 327.7M | 191.4M | 35.2M | ||||||
| Total assets | 5.70B | 5.78B | 5.30B | 4.98B | 4.56B | 4.49B | 4.40B | 4.59B | 4.37B | 4.65B |
| Accounts payable | 141.6M | 191.4M | 147.7M | 179.2M | 151.1M | 146.3M | 149.0M | 162.8M | 144.8M | 188.7M |
| Current liabilities | 2.08B | 2.31B | 1.61B | 1.41B | 1.33B | 1.24B | 1.38B | 1.48B | 1.56B | 1.26B |
| Long-term debt | 1.86B | 1.58B | 1.69B | 1.48B | 1.16B | 1.17B | 972.1M | 1.11B | 737.6M | 794.7M |
| Total debt | 3.06B | 3.17B | 2.82B | 2.27B | 2.03B | 2.01B | 1.85B | 2.12B | 1.86B | 1.56B |
| Total liabilities | 3.95B | 3.89B | 3.31B | 2.90B | 2.49B | 2.41B | 2.36B | 2.60B | 2.30B | 2.06B |
| Shareholders' equity | 1.75B | 1.88B | 1.99B | 2.07B | 2.07B | 2.07B | 2.04B | 1.99B | 2.08B | 2.59B |
| Shares outstanding | 67.9M | 67.0M | 67.3M | 67.5M | 66.8M | 66.4M | 64.6M | 63.9M | 66.0M | 70.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 494.8M | 19.5M | 203.4M | 142.3M | 269.7M | 217.6M | 405.6M | 121.9M | 29.6M | 457.8M |
| Capital spending | -288.4M | -332.8M | -441.4M | -312.9M | -284.6M | -296.4M | -138.1M | -168.8M | -123.1M | -36.8M |
| Free cash flow | 206.4M | -313.3M | -238.0M | -170.6M | -14.8M | -78.8M | 267.5M | -46.9M | -93.5M | 421.0M |
| Cash from investing | -286.1M | -336.9M | -435.3M | -312.3M | -288.1M | -330.8M | -129.1M | 110.4M | -65.7M | -414.9M |
| Cash from financing | -108.5M | 217.3M | 420.4M | 113.6M | -69.3M | 96.3M | -338.0M | 20.5M | -361.8M | -261.4M |
| Dividends paid | -122.0M | -127.7M | -121.2M | -124.3M | -118.7M | -114.9M | -237.8M | -241.1M | -126.9M | |
| Share buybacks | 2.65B | 1.85B | 0 | -423.7M | ||||||
| Change in cash | 101.9M | -70.6M | 177.3M | -38.6M | -90.2M | -16.3M | -74.1M | 259.3M | -414.5M | -227.4M |
Cap table
Built by 6ix from Bionime Corporation’s releases
- Common shares
- 77,285,253
- Fully diluted
- 77,285,253
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 77,285,253 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 77,285,253 |
Log in to ask 6ix AI your own questions about Bionime Corporation.